PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN...
A particular risk exists for overweight patients suffering from diabetes type 2, e.g. patients with a body mass index (BMI)>30. In these patients the risks of diabetes overlap with the risks of overweight, lead